本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Elevance Health

311.53
-5.3400-1.69%
盤後311.530.00000.00%19:55 EDT
成交量:105.03萬
成交額:3.30億
市值:687.56億
市盈率:12.36
高:319.81
開:318.42
低:311.25
收:316.87
52周最高:444.37
52周最低:273.71
股本:2.21億
流通股本:2.21億
量比:0.67
換手率:0.48%
股息:6.84
股息率:2.20%
每股收益(TTM):25.21
每股收益(LYR):25.21
淨資產收益率:13.25%
總資產收益率:4.35%
市淨率:1.57
市盈率(LYR):12.36

資料載入中...

2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/20

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/15

重要事件披露

Form 8-K - Current report
2024/04/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/18

重要事件披露

Form 8-K - Current report
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/24

重要事件披露

Form 8-K - Current report
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/19

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]